未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
A IMMUNOTHERAPEUTIC ADVANCES IN GLIOMA MANAGEMENT: THE RISE OF VACCINE-BASED APPROACHES Shah, M.; Awuah, W.; Tan, J.; Ranganathan, S.; Darko, K.; Tenkorang, P. Ohenewaa; Adageba, B.; Ahluwalia, A.; Shet, V; Kundu, M.; Aderinto, N.; Abdul-Rahman, T.; Atallah, O. 分享 收藏
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer 抑制CDC7增强PARP抑制剂在晚期卵巢癌中的抗肿瘤功效 Liu, Shini; Deng, Peng; Yu, Zhaoliang; Hong, Jing Han; Gao, Jiuping; Huang, Yulin; Xiao, Rong; Yin, Jiaxin; Zeng, Xian; Sun, Yichen; Wang, Peili; Geng, Ruizi; Chan, Jason Yongsheng; Guan, Peiyong; Yu, Qiang; Teh, Bin-Tean; Jiang, Qingping; Xia, Xiaojun; Xiong, Ying; Chen, Jianfeng; Huo, Yongliang; Tan, Jing 分享 收藏
Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability 集合管癌治疗易损性的综合分子表征 Guan, Peiyong; Chen, Jianfeng; Mo, Chengqiang; Fukawa, Tomoya; Zhang, Chao; Cai, Xiuyu; Li, Mei; Hong, Jing Han; Chan, Jason Yongsheng; Ng, Cedric Chuan Young; Lee, Jing Yi; Wong, Suet Far; Liu, Wei; Zeng, Xian; Wang, Peili; Xiao, Rong; Rajasegaran, Vikneswari; Myint, Swe Swe; Lim, Abner Ming Sun; Yeong, Joe Poh Sheng; Tan, Puay Hoon; Ong, Choon Kiat; Xu, Tao; Du, Yiqing; Bai, Fan; Yao, Xin; Teh, Bin Tean; Tan, Jing 分享 收藏
分享 收藏
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression 靶向AURKA通过减弱MYC表达诱导CREBBP缺陷的b细胞恶性肿瘤的合成致死率 Sun, Yichen; Chen, Jianfeng; Hong, Jing Han; Xiao, Rong; Teng, Yan; Wang, Peili; Deng, Peng; Yu, Zhaoliang; Chan, Jason Yongsheng; Chai, Kelila Xin Ye; Gao, Jiuping; Wang, Yali; Pan, Lu; Liu, Lizhen; Liu, Shini; Teh, Bin Tean; Yu, Qiang; Lim, Soon Thye; Li, Wenyu; Xu, Banglao; Ong, Choon Kiat; Tan, Jing 分享 收藏
Integrative Multi-Omics Enhancer Activity Profiling Identifies Therapeutic Vulnerabilities in Cholangiocarcinoma of Different Etiologies Hong, Jing Han; Yong, Chern Han; Heng, Hong Lee; Chan, Jason Yongsheng; Lau, Mai Chan; Chen, Jianfeng; Lee, Jing Yi; Lim, Abner Herbert; Li, Zhimei; Guan, Peiyong; Chu, Pek Lim; Ng, Sheng Rong; Yao, Xiaosai; Wang, Peili; Xiao, Rong; Zeng, Xian; Sun, Yichen; Liu, Wei; Koh, Joanna; Wee, Felicia Yu Ting; Lim, Jeffrey Chun Tatt; Ng, Cedric Chuan Young; Kwek, Xiu Yi; Klanrit, Poramate; Zhang, Yaojun; Lai, Jiaming; Tai, David Wai Meng; Pairojkul, Chawalit; Dima, Simona; Popescu, Irinel; Hsieh, Sen-Yung; Yu, Ming-Chin; Yeong, Joe; Kongpetch, Sarinya; Jusakul, Apinya; Loilome, Watcharin; Tan, Patrick; Tan, Jing; Teh, Bin Tean 分享 收藏
Design and statistical analysis reporting among interrupted time series studies in drug utilization research: a cross-sectional survey Zhang, Yuanjin; Ren, Yan; Huang, Yunxiang; Yao, Minghong; Jia, Yulong; Wang, Yuning; Mei, Fan; Zou, Kang; Tan, Jing; Sun, Xin 分享 收藏
The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women CD39作为肿瘤特异性T细胞标志物在亚洲女性三阴性乳腺癌中的预后价值 Meng, Jia; Tan, Jing Ying Tira; Joseph, Craig Ryan; Ye, Jiangfeng; Lim, Jeffrey Chun Tatt; Goh, Denise; Xue, Yuezhen; Lim, Xinru; Koh, Valerie Cui Yun; Wee, Felicia; Tay, Timothy Kwang Yong; Chan, Jaason Yongsheng; Ng, Cedric Chuan Young; Iqbal, Jabed; Lau, Mai Chan; Lim, Hsuen Elaine; Toh, Han Chong; Teh, Bin Tean; Dent, Rebecca Alexandra; Tan, Puay Hoon; Yeong, Joe Poh Sheng 分享 收藏
Sample size calculations for randomized controlled trials with repeatedly measured continuous variables as primary outcomes need improvements: a cross-sectional study Ren, Yan; Jia, Yulong; Yang, Min; Yao, Minghong; Wang, Yuning; Mei, Fan; Li, Qianrui; Li, Ling; Li, Guowei; Huang, Yunxiang; Zhang, Yuanjin; Xu, Jiayue; Zou, Kang; Tan, Jing; Sun, Xin 分享 收藏
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer RB1活性的药理学调节可减轻局部晚期直肠癌对新辅助化疗的抵抗力 Yu, Zhaoliang; Deng, Peng; Chen, Yufeng; Lin, Dezheng; Liu, Shini; Hong, Jinghan; Guan, Peiyong; Chen, Jianfeng; Zhong, Min-er; Chen, Jinghong; Chen, Xiaochuan; Sun, Yichen; Wang, Yali; Wang, Peili; Cai, Zerong; Chan, Jason Yongsheng; Huang, Yulin; Xiao, Rong; Guo, Yaoyu; Zeng, Xian; Wang, Wenyu; Zou, Yifeng; Yu, Qiang; Lan, Ping; Teh, Bin Tean; Wu, Xiaojian; Tan, Jing 分享 收藏
First-line osimertinib for patients with advanced NSCLC harboring EGFR mutations: A real-world study Ji, W.; Jiang, D.; Zhang, J.; Zhang, H.; Wang, Q.; Cang, S.; Li, X.; Tan, J.; Xiang, Y.; Li, X.; Liu, A.; Lu, S. 分享 收藏
Real-world molecular testing, treatment patterns and clinical outcomes in Chinese advanced NSCLC patients, who have progressed on first-line EGFR-TKI therapy (PISCES) Tian, P.; Wu, L.; Zhou, C.; Tan, J.; Wang, K.; Luo, F.; Liu, Y.; Guo, Y.; Li, Y.; Liu, Z.; Gong, Y.; Wang, Y.; Li, W. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
